Released Aug 8, 2016, after the close
10-Q filed Aug 8, 2016, 39 days after period end · 0001104659-16-137990
Q2 2016 · 10-Q
Revenue$54.35M$54.35M +95.9% vs Q2 2015−17.7% vs Q1 2016
Net Income-$21.70M-$21.70M no prior Q2 2015 on fileN/M vs Q1 2016
EPS Diluted-$0.15-$0.15 N/M vs Q2 2015N/M vs Q1 2016
Operating Income-$15,315,000N/M
Operating Cash Flowderived-$6,263,000N/M
Free Cash Flowderived-$6,878,000N/M
Margins · derived
Operating margin-28.2%+123.2 pt vs Q2 2015
Net margin-39.9%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Revenue | $54.35M | $27.74M | $6.84M | $9.66M |
| Net Income | -$21.70M | — | — | — |
| EPS Diluted | -$0.15 | -$0.34 | -$0.44 | -$0.57 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR